Introduction
============

**S**teroid use has prolonged ambulation in Duchenne muscular dystrophy (DMD) and combined with advances in respiratory care overall management has improved such that cardiac manifestations have become the major cause of death. Unfortunately, there is no consensus for DMD-associated cardiac disease management.

Purpose
=======

To assess effects of steroid use alone or in combination with angiotensin converting enzyme inhibitors (ACEI) or angiotension receptor blocker (ARB) on cardiac magnetic resonance imaging (CMR) derived circumferential strain (ε~cc~).

Methods
=======

We reviewed our DMD CMR database and medical records from February 2006 to 2010. The study cohort was divided into patients receiving steroids alone (Group A) or steroids plus ACEI or ARB (Group B). Analysis of covariance was used to assess the effect of medication on heart rate (HR), left ventricular ejection fraction (LVEF), mass (LVM), end diastolic volume (LVEDV) and ε~cc~ with age as a continuous covariate.

Results
=======

A total of 206 studies from 136 DMD subjects were included in the analysis. Group A (114 studies) was younger than Group B (92 studies)(10±2.4 vs. 12.4±3.2 years, p\< 0.0001). However, HR, LVEF, LVEDV and LVM were not different between the two groups (Table [1](#T1){ref-type="table"}). ε~cc~ magnitude was significantly lower in Group B (-13.8±1.9 vs -12.8±2.0, p= 0.0004), but age correction using covariance analysis eliminated this effect (Table [2](#T2){ref-type="table"}). After mean follow-up of 15 months, ε~cc~ of neither group improved compared with baseline (Table [3](#T3){ref-type="table"}).

###### 

DMD Patients characteristics

  Parameter                    Steroid Only (A) (n=114)   Steroid plus ACEI_ARB (B) (n=92)   P-value
  ---------------------------- -------------------------- ---------------------------------- ----------
  Age (yrs)                    10.0 ± 2.4                 12.4 ± 3.2                         \<0.0001
  Heart Rate (bpm)             101 ± 19                   104 ± 15                           0.2498
  LVEDV (mL)                   82.5 ± 21.8                86.7 ± 24.8                        0.2023
  LVM (g)                      58.6 ± 19.4                62.1 ± 19.8                        0.1031
  EF (%)                       64.2 ± 6.1                 62.8 ± 7.5                         0.1414
  ε~cc~ (%)                    -13.8 ± 1.9                -12.8 ± 2.0                        0.0004
  Steroid dose (gram/kg/day)   0.7 ± 0.29                 0.6 ± 0.22                         0.4838
  ACE-I dose (gram/kg/day)     N/A                        0.16 ± 0.08                        N/A
  ARB dose (gram/kg/day)       N/A                        0.73 ± 0.29                        N/A

Abbreviations: ACE-I = Angiotension Converting Enzyme Inhibitor, ARB = Angiotension Receptor Block, bpm = beat per minute, Clinic Prior to CMR = Previous Clinic Visiting Documenting Medication and Dose Prior to Cardiac Magnetic Resonance Imaging Study, DMD = Duchenne Muscular Dystrophy, ε~cc~ = Circumferential Strain, EF = Ejection Fraction, LVEDV = Left Ventricular Endiastolic Volume, LVM = Left Ventricular Mass.

###### 

Analysis of covariance summary results: Comparisons between steroid only vs. steroid plus ACEI_ARB (medication) adjusted for age as continuous variable.

                      Medication     Age                      
  ------------------- -------------- --------- -------------- ----------
  Response Variable   F-statistics   P-value   F-statistics   P-value
                                                              
  Heart Rate (bpm)    1.11           0.2930    0.00           0.9979
  LVEDV (mL)          1.33           0.2503    37.01          \<0.0001
  LVM (g)             2.19           0.1405    64.38          \<0.0001
  EF (%)              0.03           0.8594    9.10           0.0029
  ε~cc~ (%)           1.74           0.1885    30.85          \<0.0001

Abbreviations: ACE-I = Angiotension Converting Enzyme Inhibitor, ARB = Angiotension Receptor Block, bpm = beat per minute, ε~cc~ = Circumferential Strain, EF = Ejection Fraction, LVEDV = Left Ventricular Endiastolic Volume, LVM = Left Ventricular Mass.

###### 

DMD Serial Study Characteristics

  Group        Group A (Steroids)   Group B (Steroids plus)   Group A to B                                                                     
  ------------ -------------------- ------------------------- -------------- ------------- ------------- --------- ------------- ------------- ---------
  CMR Study    Study 1              Study 2                   P-value        Study 1       Study 2       P-value   Study 1       Study 2       P-value
  Age (yrs)    9.30 ± 1.5           10.5 ± 1.6                \<0.005        11.7 ± 3.4    12.97 ± 3.4   0.148     10.8 ± 2.5    12.0 ± 2.2    0.252
  HR (bpm)     101 ± 21             99 ± 16                   0.762          105 ± 14      105 ± 15      0.996     100 ± 14      102 ± 18      0.682
  LVEDV (mL)   82.7 ± 19.3          86.5 ± 21.6               0.494          84.9 ± 29.2   90.0 ± 30.8   0.499     85.6 ± 18.6   81.2 ± 15.6   0.556
  LVM (g)      57.1 ± 15.1          57.7 ± 16.9               0.890          60.9 ± 21.4   65.0 ± 21.4   0.478     61.3 ± 32.2   60.1 ± 14.0   0.909
  EF (%)       64.6 ± 6.3           64.4 ± 5.8                0.906          64.9 ± 6.7    62.2 ± 9.1    0.194     61.2 ± 5.0    63.8 ± 5.8    0.261
  ε~cc~ (%)    -14.3 ± 1.6          -13.7 ± 1.5               0.135          -13.4 ± 1.7   -12.1 ± 1.6   0.007     -13.2 ± 1.8   -11.9 ± 2.7   0.179

Conclusions
===========

In a large consecutive database of DMD patients, serial CMR studies demonstrate that current and standard treatment strategy at our institution has little effect on DMD-associated cardiac disease. The failure of current regimens supports the need for rigorous prospective clinical trials to identify effective treatment regimens.
